United Therapeutics Corporation

United Therapeutics Corporationverified

UTHR

Price:

$363.475

Market Cap:

$16.23B

United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertension (PAH) to diminish symptoms associated with exercise; Tyvaso, an inhaled formulation of prostacyclin analogue treprostinil to enhance the exercise ability in PAH patients and pulmonary hypertension associated with interstitial lung disease (PH-ILD); Orenitram, a tablet dosage form of treprostinil to enhance the exercise capacity in PAH patients; Unit...[Read more]

Industry

Biotechnology

IPO Date

1999-06-17

Stock Exchange

NASDAQ

Ticker

UTHR

The Dividend Yield as of December 2024 (TTM) for United Therapeutics Corporation (UTHR) is 0%

According to United Therapeutics Corporation’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

United Therapeutics Corporation (UTHR) Historical Dividend Yield (quarterly & annually)

How has UTHR Dividend Yield performed in the past?

The mean historical Dividend Yield of United Therapeutics Corporation over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), UTHR's Dividend Yield was at its highest in in the December 2014 quarter at 0%. The Dividend Yield was at its lowest in in the December 2014 quarter at 0%.

Quarterly (TTM)
Annual

Average

0%

Median

0%

Minimum

0%

Maximum

0%

United Therapeutics Corporation (UTHR) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of United Therapeutics Corporation Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Dividend Yield = 0%

Minimum Annual Increase = 0%

Minimum Annual Dividend Yield = 0%

Quarterly (TTM)
Annual
YearDividend YieldChange
20230%0%
20220%0%
20210%0%
20200%0%
20190%0%
20180%0%
20170%0%
20160%0%
20150%0%
20140%0%

United Therapeutics Corporation (UTHR) Average Dividend Yield

How has UTHR Dividend Yield performed in the past?

The current Dividend Yield of United Therapeutics Corporation (UTHR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

0%

5-year avg

0%

10-year avg

0%

United Therapeutics Corporation (UTHR) Dividend Yield vs. Peers

How is UTHR’s Dividend Yield compared to its peers?

United Therapeutics Corporation’s Dividend Yield is less than Incyte Corporation (0%), less than Alnylam Pharmaceuticals, Inc. (0%), less than Ultragenyx Pharmaceutical Inc. (0%), less than Apellis Pharmaceuticals, Inc. (0%), less than Replimune Group, Inc. (0%), less than Nuvalent, Inc. (0%), less than Ventyx Biosciences, Inc. (0%), less than Ascendis Pharma A/S (0%), less than MannKind Corporation (0%), less than Larimar Therapeutics, Inc. (0%), less than Day One Biopharmaceuticals, Inc. (0%), less than Kiniksa Pharmaceuticals, Ltd. (0%), less than BeiGene, Ltd. (0%), less than Akero Therapeutics, Inc. (0%), less than Blueprint Medicines Corporation (0%), less than Vaxcyte, Inc. (0%), less than Legend Biotech Corporation (0%),

Build a custom stock screener for United Therapeutics Corporation (UTHR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like United Therapeutics Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

United Therapeutics Corporation (UTHR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like United Therapeutics Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Dividend Yield?

How can you use the Dividend Yield?

What is United Therapeutics Corporation's Dividend Yield?

How is the Dividend Yield calculated for United Therapeutics Corporation (UTHR)?

What is the highest Dividend Yield for United Therapeutics Corporation (UTHR)?

What is the 3-year average Dividend Yield for United Therapeutics Corporation (UTHR)?

What is the 5-year average Dividend Yield for United Therapeutics Corporation (UTHR)?

How does the current Dividend Yield for United Therapeutics Corporation (UTHR) compare to its historical average?